{"id":"W4410569892","doi":"10.1007/s11523-025-01146-4","title":"Olaparib Monotherapy or in Combination with Abiraterone for the Treatment of Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC) and a BRCA Mutation","year":2025,"lang":"en","type":"review","venue":"Targeted Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"AstraZeneca","keywords":"Medicine; Olaparib; Abiraterone; Prostate cancer; Oncology; PARP inhibitor; Internal medicine; Docetaxel; Cancer; BRCA mutation; Ovarian cancer; Poly ADP ribose polymerase; Androgen receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005075493,0.0002529385,0.000752428,0.0004056637,0.0001285014,0.0005356278,0.0002279146,0.0002803914,0.002290355],"category_scores_gemma":[0.000924819,0.000109356,0.0006754777,0.0003874316,0.0001851879,0.0003137851,0.0002037748,0.0008933724,0.0003976583],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002787386,"about_ca_system_score_gemma":0.0005248522,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002776016,"about_ca_topic_score_gemma":0.00143383,"domain_scores_codex":[0.9997125,0.0001228757,0.00002735361,0.00004492086,0.00006317192,0.00002902782],"domain_scores_gemma":[0.9995542,0.000135014,0.0001533877,0.00002582827,0.00002905375,0.0001024878],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.09440894,0.001184007,0.01426101,0.002082904,0.002323415,0.0004276127,0.0001034714,0.003011372,0.0173673,0.001062753,0.009746375,0.8540209],"study_design_scores_gemma":[0.1304143,0.2086662,0.3055866,0.003545069,0.009413038,0.01893889,0.0006949899,0.02018346,0.03177047,0.02153867,0.2488096,0.0004386713],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"review","genre_scores_codex":[0.7730933,0.1980086,0.003721628,0.003878758,0.0005995904,0.0003620695,0.002079076,0.0003334745,0.01792348],"genre_scores_gemma":[0.9750178,0.01944574,0.001209598,0.0009034495,0.0002376268,0.00008251084,0.001062413,0.00001716543,0.002023728],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.002290355,"threshold_uncertainty_score":0.007662058,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04601313563003731,"score_gpt":0.3846335911876247,"score_spread":0.3386204555575874,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}